Pay in 4 interest-free payments of $6.53 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
**All Pharmacies typically require 2 to 7 business days to process and ship orders** GLP-1 Standard (Brand-Name) Treatment Plan - $25/month + the cost of medication GLP-1 Standard Treatment Plan $25/month + the cost of medication If you and your provider determine that a medication such as Zepbound (tirzepatide), Mounjaro (tirzepatide) Wegovy (semaglutide), or Ozempic (semaglutide) is the right choice for you, you will be invoiced for a Standard (Brand-Name) treatment plan
Despite existing treatment options, there is still a clear unmet need for this group
Our main export markets span North America, Europe, and Asia, reflecting our global presence
What sets us apart is our comprehensive approach
Survodutide (BI 456906), developed by Boehringer Ingelheim and Zealand Pharma, is a once-weekly injectable GLP-1/glucagon dual receptor agonist
"I wanted to do something nice for me
US$ 22.36
US$ 20.83
US$ 26.40
US$ 23.54
US$ 23.09
US$ 27.44
US$ 20.18
US$ 29.88
